IEXP helps pharmaceutical companies to the successful launch of therapies by gathering real world data and patient insights in order to determine with PROM, PREM and value indicators te real impact of a therapy in the lives of patients and their social environment. Key messages for prescriptor claims, as well as data for a smoother access help to a better prescription, improved adherence and shorter launch times. IEXP takes care of all the value chain from patient recruiting through our hospital and patient association network (also in Europe and Brazil), qualitative research, quantitative research and artificial intelligence, scaling on platforms for international data gathering up to communication to different stakeholders in and outside the company.
IEXP takes care of all the value chain from patient recruiting through our hospital and patient association network (also in Europe and Brazil), qualitative research, quantitative research and artificial intelligence, scaling on platforms for international data gathering up to communication to different stakeholders in and outside the company.We work with many patient associations -especially in respiratory, oncological and neurological areas- and also with a high number of non associated patients through a network of hospital agreements.
We help improve therapeutic adherence with a participatory health approach, scientific evidence and use of real word evidence and real world data.
We contribute to the highest data quality, efficient use of technologies and reduction of drop out with a participatory action and health research approach according to internationally validated guides.
In the new pharmaceutical scenarios, patient centricity is a key aspect in both clinical trials, as in the approval of therapies, as well as the improvement of adherence.IEXP assumes the integral management of the patient centricity offering the following services in close collaboration with the access, medical, marketing and patient access areas:
Listening to patients and stakeholders in the ecosystem allows a complete view of market and customer needs.
Aprobación cada vez más dependiente de PROMS y PREMS.
Protocolos mas eficientes y rentables.
Understand the complete context of the client: meaningful data.
Incorporation of indicators and validated scales.
Identify critical profiles and their needs.
Patient-centered clinical prescription as an impact reinforcement to the prescription based on scientific evidence.
Create lasting and meaningful relationships with healthcare professionals, associations and other actors in the ecosystem.